The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen… Read More »Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
With several smaller drug and biotech companies still to report fourth-quarter earnings, today’s article highlights four which are expected to deliver earnings surprises in their… Read More »4 Drug/Biotech Stocks Set To Deliver Earnings Surprises
The wave of biotech IPOs continued on Friday, with seven companies in the biotech or health-care space making their market debuts. Among them was a… Read More »7 Newly Listed Biotech/Health-Care Stocks – And A Look At Their Market Debuts
The author of today’s article notes that, every year at the J.P. Morgan Healthcare Conference, “big mergers and acquisitions, as well as important clinical trial… Read More »How To Profit In A Different Landscape For Biotech Catalysts
While the first coronavirus vaccine has received emergency use authorization from the FDA, the author of today’s article points out that “The coronavirus vaccine race… Read More »The Best Bets Right Now In The Ongoing COVID Vaccine Race For Aggressive – And Cautious – Investors
The author of today’s article notes that, while the “upside in biotech sector has been led by positive developments at small companies, primarily the ones… Read More »4 ‘Strong Buy’/‘Buy’ Biotech Stocks
“While volatility still permeates the broad market, one segment has seen a fairly consistent upward trend through the bulk of the year. That segment is,… Read More »The Tailwinds Behind Biotech – And How Both Traders And Investors Can Profit With ETFs
Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication… Read More »Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in… Read More »Why This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna